More Than 200 Companies Advance Trial Management with Veeva CTMS

Core Insights - Veeva Systems announced that over 200 companies, including 17 of the top 20 biopharmas, utilize Veeva CTMS to enhance trial efficiency and collaboration [1] - The increasing complexity of studies and data volumes has led biopharmas and CROs to centralize data and documents with Veeva CTMS, streamlining processes [1][2] - Veeva CTMS allows clinical teams to proactively manage studies, quickly identify issues, and maintain compliance with global regulations [2][3] Company Overview - Veeva Systems is recognized as the global leader in cloud software for the life sciences industry, serving over 1,000 customers, from large biopharmaceutical companies to emerging biotechs [4] - The company is committed to innovation, product excellence, and customer success, balancing the interests of all stakeholders [4] Product Innovations - Veeva continues to deliver clinical innovations to help biopharmas adapt to changes in trial operating models and evolving regulations [3] - New advancements in Veeva CTMS include capabilities that support both insourced and outsourced operating models, with three product releases per year to enhance flexibility [3][6] - Features such as automated data transfers from CROs to sponsors and oversight issue tracking are designed to improve visibility and speed in trial management [6]